| 4-(4-BroMo-3-(1,3-dioxolan-2-yl)phenoxy)benzonitrile |
1217366-74-9 |
|
| 1-BroMo-5-isopropoxy-2-Methyl-4-nitrobenzene |
1202858-68-1 |
|
| 9-([1,1-biphenyl]-3-yl)-9H-carbazole |
1221237-87-1 |
|
| 1-Ethylcyclohexyl methacrylate |
274248-09-8 |
|
| 2-(3'-Chloro[1,1'-biphenyl]-4-yl)-4,6-diphenyl-1,3,5-triazine |
1443049-84-0 |
|
| (6S,9R)-6-(2,3-Difluorophenyl)-6,7,8,9-tetrahydro-9-[[tris(1-methylethyl)silyl]oxy]-5H-cyclohepta[b]pyridin-5-one |
1190363-46-2 |
|
| Lorlatinib (PF-06463922) |
1454846-35-5 |
|
| |
| 7H-Pyrrolo[2,3-d]pyriMidine-6-carboxaMide, 2-chloro-7-cyclopentyl-N,N-diMethyl- |
1211443-61-6 |
|
| |
| 5-Methyl-2-(1-Methylethoxy)-4- (4-piperidinyl)- BenzenaMine hydrochloride (1:2) |
1380575-45-0 |
|
| (αS,βR)-β-(2,5-Difluorophenyl)-β-hydroxy-α-Methyl-1H-1,2,4-triazole-1-butanenitrile |
241479-74-3 |
|
| (2R,3R)-3-(2,5-Difluorophenyl)-3-hydroxy-2-Methyl-4-(1H-1,2,4-triazol-1-yl)thiobutyraMide |
368421-58-3 |
|
| Maytansinoid dM4 |
799840-96-3 |
|
| N-[(9H-Fluoren-9-ylMethoxy)carbonyl]-4-[[[(4S)-hexahydro-2,6-dioxo-4-pyriMidinyl]carbonyl]aMino]-L-phenylalanine |
1253282-31-3 |
|
| |
| (1S,3R,4R)-3-(Boc-aMino)-4-hydroxy-cyclohexanecarboxylic acid ethyl ester |
365997-33-7 |
|
| 10-Nitrocamptothecin |
86639-62-5 |
|
| (+)-GALLOCATECHIN |
970-73-0 |
|
| 2-(9H-Fluoren-2-yl)-4,4,5,5-tetramethyl-[1,3,2]dioxaborolane |
922706-40-9 |
|
| N-(biphenyl-4-yl)-N-(4'-broMobiphenyl-4-yl)-9,9-diMethyl-9H-fluoren-2-aMine |
1268621-99-3 |
|
| 5-broMopyrazolo[1,5-a]pyridine |
1060812-84-1 |
|
| LUCIDENIC ACID D2(SH) |
98665-16-8 |
|
| Ethyl 2-((5-chloropyridin-2-yl)amino)-2-oxoacetate hydrochloride |
1243308-37-3 |
|
| Dalbavancin IMpurity - A40926-B0 |
102961-72-8 |
|
| (2S,4S)-4-FLUORO-PYRROLIDINE-2-CARBOXYLIC ACID |
2438-57-5 |
|
| 5-Carboxy-8-hydroxyquinoline |
5852-78-8 |
|
| 1H-BenziMidazole, 6-(2-chloro-5-fluoro-4-pyriMidinyl)-4-fluoro-2-Methyl-1-(1-Methylethyl)- |
1231930-42-9 |
|
| |
| |
